A multicentric, post-marketing surveillance to monitor the safety and reactogenicity of GlaxoSmithKline Biologicals hepatitis A vaccine [hepatitis A vaccine inactivated; Havrix] administered in Korean population.

Trial Profile

A multicentric, post-marketing surveillance to monitor the safety and reactogenicity of GlaxoSmithKline Biologicals hepatitis A vaccine [hepatitis A vaccine inactivated; Havrix] administered in Korean population.

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 Nov 2008

At a glance

  • Drugs Hepatitis A vaccine inactivated (Primary)
  • Indications Hepatitis A
  • Focus Adverse reactions
  • Most Recent Events

    • 15 Oct 2008 Actual start date changed from Feb 2005 to Jun 2005 as reported by ClinicalTrials.gov
    • 24 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top